目的 研究促红细胞生成素（EPO）对新生大鼠感染性脑损伤后神经细胞增生与凋亡的影响。方法 2 日龄新生大鼠26 只随机分为3 组：对照组（腹腔注入等量生理盐水）、脂多糖（LPS）组（腹腔注入0.6 mg/kg LPS）及EPO 干预组（腹腔注入0.6 mg/kg LPS + 5 000 U/kg EPO），各组均连续注药5 d，同时腹腔注射5-溴脱氧尿嘧啶核苷（BrdU）（50 mg/kg，Qd，连续5 d），最后1 次用药24 h 后采用免疫组化方法检测脑组织海马齿状回颗粒下层BrdU 和活化半胱氨酸天冬氨酸蛋白酶-3（Caspase-3）的表达情况。结果 EPO 干预组、LPS组脑组织海马齿状回单位面积内神经细胞数均显著低于对照组（P<0.05），但EPO 干预组与LPS 组比较差异无统计学意义。EPO 干预组BrdU 阳性表达较LPS 组显著增多（51±9 vs 29±6），但仍较对照组（67±12）减少（P<0.05）。EPO 干预组活化的Caspase-3 阳性表达较LPS 组显著减少（27.9±1.5 vs 34.0±1.3），但仍多于对照组（21.0±1.7），差异均有统计学意义（P<0.05）。结论 EPO 可促进感染性新生大鼠脑损伤后海马区新生神经细胞的增生并减轻神经细胞的凋亡。
Abstract
Objective To investigate the effects of erythropoietin (EPO) on the neuronal proliferation and apoptosis in neonatal rats after infection-induced brain injury and the neuroprotective mechanism of EPO in neonatal rats with infection-induced brain injury. Methods Twenty-six two-day-old neonatal rats were randomly divided into 3 groups: control group (intraperitoneally given an equal volume of normal saline), lipopolysaccharide (LPS) group (intraperitoneally given LPS 0.6 mg/kg), and EPO group (intraperitoneally given LPS 0.6 mg/kg and EPO 5 000 U/kg). These groups were injected with respective drugs for 5 consecutive days. Meanwhile, each group was intraperitoneally injected with 5-bromo-2'-deoxyuridine (BrdU) (50 mg/kg) once a day for 5 consecutive days. The expression of BrdU and cleaved Caspase-3 in the hippocampal dentate gyrus was detected by immunohistochemistry at 24 hours after the last injection. Results The number of neuronal cells in the hippocampal dentate gyrus in the LPS and EPO groups was significantly greater than in the control group (P<0.05), but there was no significant difference between the LPS and EPO groups. The EPO group had a significantly higher number of BrdU-positive cells in the subgranular zone of hippocampal dentate gyrus than the LPS group (51±9 vs 29±6; P<0.05), but a significantly lower number of BrdU-positive cells than the control group (51±9 vs 67±12; P<0.05). The EPO group had a significantly lower number of cleaved Caspase-3-positive cells in the subgranular zone of hippocampal dentate gyrus than the LPS group (27.9±1.5 vs 34.0±1.3; P<0.05), but a significantly higher number of cleaved Caspase-3-positive cells than the control group (27.9±1.5 vs 21.0±1.7; P<0.05). Conclusions EPO can promote hippocampal neuronal proliferation and reduce neuronal apoptosis in neonatal rats after infection-induced brain injury.
关键词
促红细胞生成素 /
5-溴脱氧尿嘧啶核苷 /
活化半胱氨酸天冬氨酸蛋白酶-3 /
新生大鼠
Key words
Erythropoietin /
BrdU /
Cleaved Caspase-3 /
Neonatal rats
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] Johnston MV, Fatemi A, Wilson MA, et al. Treatment advances in neonatal neuroprotection and neurointensive care[J]. Lancet Neurol, 2011, 10(4): 372-382.
[2] Han W, Song J, Liu A, et al. Trends in live births in the past 20 years in Zhengzhou, China[J]. Acta Obstet Gynecol Scand, 2011, 90(4): 332-337.
[3] Rutherford M, Ramenghi LA, Edwards AD, et al. Assessment of brain tissue injury after moderate hypothermia in neonates with hypoxic-ischaemic encephalopathy: a nested substudy of a randomised controlled trial[J]. Lancet Neurol, 2010, 9(1): 39-45.
[4] 张鹏, 程国强. 亚低温治疗新生儿缺氧缺血性脑病的研究进 展[J]. 中国当代儿科杂志, 2013, 15(10): 918-922.
[5] 刘敬, 杨于嘉, 封志纯."早产儿脑损伤诊断与防治专家共识" 解读[J]. 中国当代儿科杂志, 2012, 14(12): 885-887.
[6] 徐发林, 庄方莉, 白琼丹, 等. 细菌脂多糖对不同成熟度新 生小鼠脑发育的影响[J]. 实用儿科临床杂志, 2012, 27(8): 611-613.
[7] Mallard C, Wang X. Infection-induced vulnerability of perinatal brain injury[J]. Neurol Res Int, 2012, 2012: 102153.
[8] Graf AE, Haines KM, Pierson CR, et al. Perinatal inflammation results in decreased oligodendrocyte numbers in adulthood[J]. Life Sci, 2014, 94(2): 164-171.
[9] Du X, Fleiss B, Li H, et al. Systemic stimulation of TLR2 impairs neonatal mouse brain development[J]. PloS One, 2011, 6(5): e19583.
[10] Neubauer AP, Voss W, Wachtendorf M, et al. Erythropoietin improves neurodevelopmental outcome of extremely preterm infants[J]. Ann Neurol, 2010, 67(5): 657-666.
[11] Fan X, Heijnen CJ, van der KOOIJ MA, et al. Beneficial effect of erythropoietin on sensorimotor function and white matter after hypoxia-ischemia in neonatal mice[J]. Pediatr Res, 2011, 69(1): 56-61.
[12] Zhu C, Kang W, Xu F, et al. Erythropoietin improved neurologic outcomes in newborns with hypoxic-ischemic encephalopathy[J]. Pediatrics, 2009, 124(2): e218-226.
[13] Chen H, Spagnoli F, Burris M, et al. Nanoerythropoietin is 10-times more effective than regular erythropoietin in neuroprotection in a neonatal rat model of hypoxia and ischemia[J]. Stroke, 2012, 43(3): 884-887.
[14] Kumral A, Uysal N, Tugyan K, et al. Erythropoietin improves longterm spatial memory deficits and brain injury following neonatal hypoxia-ischemia in rats[J]. Behav Brain Res, 2004, 153(1): 77-86.
[15] Shen Y, Yu HM, Yuan TM, et al. Erythropoietin attenuates white matter damage, proinflammatory cytokine and chemokine induction in developing rat brain after intra-uterine infection[J]. Neuropathology, 2009, 29(5): 528-535.
[16] Mizuno K, Hida H, Masuda T, et al. Pretreatment with low doses of erythropoietin ameliorates brain damage in periventricular leukomalacia by targeting late oligodendrocyte progenitors: a rat model[J]. Neonatology, 2008, 94(4): 255-266.
[17] Taupin P. BrdU immunohistochemistry for studying adult neurogenesis: paradigms, pitfalls, limitations, and validation[J]. Brain Res Rev, 2007, 53(1): 198-214.
基金
河南省教育厅自然科学研究计划项目（13A320664）；河南省高等学校青年骨干教师资助计划（2012ggjs-015）。
PDF(3563 KB)
